Hyperbaric Oxygen Therapy and Diabetes: How to Navigate Blood Sugar Management
"Discover how patients with diabetes manage their blood glucose levels during hyperbaric oxygen treatment, addressing fears and adapting treatment plans for better outcomes."
Hyperbaric oxygen therapy (HBOT) is increasingly used to treat wounds that are slow to heal, especially in patients with diabetes. This therapy involves breathing 100% oxygen in a pressurized chamber, which helps to increase oxygen levels in the blood and promote healing. However, HBOT can also affect blood glucose levels, leading to concerns among patients with diabetes.
A recent study explored how individuals with diabetes manage their blood glucose levels while undergoing HBOT. The research highlights the emotional and physical challenges patients face, revealing strategies they use to maintain stable blood sugar and avoid complications during treatment.
Understanding these experiences can help healthcare providers offer better support and personalized care, making HBOT a safer and more effective option for people with diabetes.
Why Blood Sugar Management Matters
Diabetes can complicate wound healing and increase the clinical challenges involved in treating diabetic foot disease. Hyperbaric oxygen therapy is therefore discussed as an adjunctive treatment rather than a replacement for diabetes care. Blood sugar management remains an important part of safely navigating treatment, although the specific effects of therapy can vary among individuals.
HBOT as an Adjunct
Standard care for diabetic foot ulcers remains central, while hyperbaric oxygen therapy may be added to support healing. A systematic review noted that studies had reported effects of hyperbaric oxygen on glycaemic control in patients being treated for diabetic foot disease, but also found that no previous systematic review had examined this question. Another review described HBOT as a promising adjunct to standard care for complete healing of diabetic foot ulcers. Recent clinical material further states that HBOT does not replace standard glycemic control or wound care, although one reported treatment with 100% oxygen rapidly improved insulin sensitivity and mitochondrial functionality in skeletal muscle, liver, and white adipose tissue in people with type 2 diabetes.
From Compressed Air to HBOT
Hyperbaric medicine developed around the therapeutic use of pure oxygen at elevated pressure, commonly described as 2 to 3 atmospheres absolute. Historical accounts trace the field from seventeenth-century speculation about compressed air through later decompression research and modern hyperbaric oxygen treatment. A frequently cited milestone was Behnke and Shaw’s successful 1937 use of hyperbaric oxygen therapy for decompression sickness. Later developments included portable chambers and expanding applications of hyperbaric oxygen therapies.
Why Does Blood Sugar Management Matter During HBOT?
Diabetes is a chronic condition affecting millions worldwide, often leading to complications like poor wound healing. Hyperbaric oxygen therapy (HBOT) enhances wound healing by increasing oxygen supply to damaged tissues. However, HBOT can lower blood glucose levels, posing risks for diabetic patients.
- Balancing Act: People with diabetes need to carefully balance their diet, medication, and activity levels to keep their blood sugar within a safe range.
- Individual Differences: Each person's response to HBOT can vary, making personalized management strategies necessary.
- Importance of Monitoring: Regular monitoring of blood glucose levels is vital to detect and address any fluctuations promptly.
What Recent Reviews Suggest
Recent research describes HBOT as an established treatment for several clinical conditions and notes that diabetes is a common comorbidity among patients receiving it. Reviews suggest possible benefits across different parts of diabetes, including effects related to insulin resistance and diabetic foot disease. One 2025 review specifically describes HBOT as providing 100% oxygen at pressures above standard atmospheric pressure in a specialized chamber. A systematic review summarized by The Health Suite identified 10 studies examining HBOT and glycaemic control in diabetes.
Limits of the Evidence
HBOT should not be treated as a guaranteed solution for diabetes-related problems. Its effects on blood sugar and healing may differ across patients, and the available evidence does not establish that it can replace standard diabetes management or wound care. A cautious approach is appropriate because treatment decisions must account for individual risks, glucose control, and the condition being treated.
Comparing Treatment Strategies
Comparative evidence indicates that both negative pressure therapy and hyperbaric oxygen therapy can be effective treatments for diabetic foot-ulcer healing. The reported comparison found that HBOT had beneficial effects on angiogenesis and significantly reduced the rate of major amputations. At the same time, research protocols have explicitly compared standard wound care plus HBOT with standard wound care alone, showing that HBOT is evaluated as an adjunct rather than a universal substitute. Hypoglycemia is also identified as a concern for patients with diabetes undergoing HBO2 therapy.
Empowering Patients Through Knowledge and Support
Managing blood glucose during hyperbaric oxygen therapy requires a comprehensive approach that addresses both the physiological and psychological aspects of treatment. By understanding the challenges patients face and providing tailored support, healthcare providers can help ensure safer, more effective outcomes. Open communication, consistent monitoring, and personalized management strategies are key to improving the patient experience and maximizing the benefits of HBOT.
An Adjunct, Not a Replacement
Reviews support hyperbaric oxygen therapy as an adjunctive measure for diabetic foot ulcers. However, the evidence is not uniformly positive: one review found no difference between HBOT and control groups in mean percentage ulcer-area reduction or mortality rate. The most balanced interpretation is that HBOT may contribute to care for selected diabetic foot ulcers while standard wound treatment and diabetes management remain essential.
Expanding Demand and Innovation
The anticipated increase in diabetes incidence is identified as a major driver of future growth in the hyperbaric oxygen therapy market. Market trend reporting also points to rising demand for portable and home-based hyperbaric chambers. These developments suggest that future discussions will involve not only clinical applications but also how therapy is delivered and accessed. The available outlooks describe opportunities and trends rather than establishing clinical outcomes for these newer delivery models.
Understanding the Metabolic Context
Type 2 diabetes involves complex metabolic dysfunction, and hyperbaric oxygen therapy has been studied as a possible way to improve hyperglycemia. Research in humans has examined its effects on whole-body glucose disposal and tissue-specific insulin sensitivity. The underlying mechanisms remain unclear, so reported metabolic improvements should be interpreted as an active area of investigation rather than a settled explanation for how HBOT works.
Personalized Treatment Decisions
For people with diabetes, navigating HBOT involves more than evaluating wound-healing claims. Blood glucose needs may require careful attention because hypoglycemia has been identified as a concern during treatment. The practical value of HBOT therefore depends on integrating it with individualized diabetes care, wound management, and clinical monitoring.